clinical decision making with immunotherapies in advanced or recurrent endometrial cancer
Published 5 months ago • 290 plays • Length 37:54Download video MP4
Download video MP3
Similar videos
-
13:29
implementation of immune checkpoint inhibitors in endometrial cancer through shared decision making
-
25:19
immunotherapy, novel therapies, and shared decision-making in advanced endometrial cancer
-
52:53
immunotherapy in advanced endometrial cancer – the new standard of care
-
0:50
role of immunotherapy in advanced endometrial cancer: recent developments and future directions
-
5:23
latest developments in immunotherapy for advanced/recurrent endometrial cancer
-
57:33
immunotherapy as a treatment cornerstone for advanced endometrial cancer
-
57:40
immunotherapy in endometrial cancer: expanding horizons
-
28:45
refining the role of immune checkpoint inhibitors in endometrial cancer
-
6:07
evolving medical treatment in advanced/recurrent endometrial cancer
-
5:22
two landmark papers change treatment paradigm for advanced endometrial cancer
-
1:00:25
expanding horizons in the treatment of endometrial cancer: esgo 2023 guide clinical practice?
-
0:50
combinatorial parpi therapies in advanced endometrial cancer
-
36:12
evolving medical treatment in advanced / recurrent endometrial cancer
-
33:06
maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
-
1:48
what is the role of immunotherapy in endometrial cancer?
-
3:17
advanced or recurrent endometrial cancer clinical trial
-
17:15
drug therapy in advanced and recurrent endometrial cancer (adilia urmancheeva)
-
4:27
current immunotherapy options for advanced endometrial cancer- 2024 ovarian cancer program
-
1:18
incorporating immunotherapy in cervical cancer and endometrial cancer treatment: 2022 esmo florida